Table of Contents Author Guidelines Submit a Manuscript
Interdisciplinary Perspectives on Infectious Diseases
Volume 2013 (2013), Article ID 370769, 5 pages
http://dx.doi.org/10.1155/2013/370769
Review Article

The Importance of IgG Avidity and the Polymerase Chain Reaction in Treating Toxoplasmosis during Pregnancy: Current Knowledge

Department of Obstetrics, Federal University of São Paulo (UNIFESP), Rua Carlos Weber, 956 Apartment, 113 Visage, Vila Leopoldina, 05303-000 São Paulo, SP, Brazil

Received 12 May 2013; Revised 25 August 2013; Accepted 4 September 2013

Academic Editor: Lúcia Galvão

Copyright © 2013 João Bortoletti Filho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. W. Black and J. C. Boothroyd, “Lytic cycle of Toxoplasma gondii,” Microbiology and Molecular Biology Reviews, vol. 64, no. 3, pp. 607–623, 2000. View at Google Scholar · View at Scopus
  2. S. Di Mario, V. Basevi, C. Gagliotti et al., “Prenatal education for congenital toxoplasmosis,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD006171, 2009. View at Google Scholar · View at Scopus
  3. E. Zemene, D. Yewhalaw, S. Abera, T. Belay, A. Samuel, and A. Zeynudin, “Seroprevalence of Toxoplasma gondii and associated risk factors among pregnant women in Jimma town, Southwestern Ethiopia,” BMC Infectious Diseases, vol. 12, article 337, 2012. View at Google Scholar
  4. J. L. Jones, A. Lopez, M. Wilson, J. Schulkin, and R. Gibbs, “Congenital toxoplasmosis: a review,” Obstetrical and Gynecological Survey, vol. 56, no. 5, pp. 296–305, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Paul, “Immunoglobulin G avidity in diagnosis of toxoplasmic lymphadenopathy and ocular toxoplasmosis,” Clinical and Diagnostic Laboratory Immunology, vol. 6, no. 4, pp. 514–518, 1999. View at Google Scholar · View at Scopus
  6. C. Garabedian, J. Le Goarant, L. Delhaes et al., “Periconceptional toxoplasmic seroconversion: about 79 cases,” Journal de Gynecologie Obstetrique et Biologie de la Reproduction, vol. 41, pp. 546–552, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Kanková, J. Sulc, R. Křivohlavá, A. Kuběna, and J. Flegr, “Slower postnatal motor development in infants of mothers with latent toxoplasmosis during the first 18 months of life,” Early Human Development, vol. 88, pp. 879–884, 2012. View at Google Scholar
  8. J. Kravetz, “Congenital toxoplasmosis,” Clinical Evidence, vol. 2010, article 0906, 2010. View at Google Scholar
  9. Y.-C. Chuang, J.-Y. Chen, D.-D. Ji, and P.-H. Su, “Congenital toxoplasmosis in a neonate with significant neurologic manifestations,” Journal of the Formosan Medical Association, vol. 111, no. 4, pp. 232–233, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Auer, A. Vander-Möse, O. Picher, J. Walochnik, and H. Aspöck, “Clinical and diagnostic relevance of the toxoplasma IgG avidity test in the serological surveillance of pregnant women in Austria,” Parasitology Research, vol. 86, no. 12, pp. 965–970, 2000. View at Google Scholar · View at Scopus
  11. O. Liesenfeld, J. G. Montoya, S. Kinney, C. Press, and J. S. Remington, “Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory,” Journal of Infectious Diseases, vol. 183, no. 8, pp. 1248–1253, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. S. L. Hazell, “Clinical utility of avidity assays,” Expert Opinion on Medical Diagnostics, vol. 1, no. 4, pp. 511–519, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. S. P. Abolghasem, M. R. Bonyadi, Z. Babaloo et al., “IgG avidity test for the diagnosis of acute Toxoplasma gondii infection in early pregnancy,” Iranian Journal of Immunology, vol. 8, no. 4, pp. 251–255, 2011. View at Google Scholar · View at Scopus
  14. I. Cañedo-Solares, L. B. Ortiz-Alegría, R. Figueroa-Damián et al., “Toxoplasmosis in pregnancy: determination of IgM, IgG and avidity in filter paper-embedded blood,” Journal of Perinatology, vol. 29, no. 10, pp. 668–672, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Yamada, A. Nishikawa, T. Yamamoto et al., “Prospective study of congenital toxoplasmosis screening with use of IgG avidity and multiplex nested PCR methods,” Journal of Clinical Microbiology, vol. 49, no. 7, pp. 2552–2556, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Wallon, J. Franck, P. Thulliez et al., “Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid,” Obstetrics and Gynecology, vol. 115, no. 4, pp. 727–733, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. H. Bessières, A. Berrebi, S. Cassaing et al., “Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis,” Memorias do Instituto Oswaldo Cruz, vol. 104, no. 2, pp. 389–392, 2009. View at Google Scholar · View at Scopus
  18. O. M. Eida, M. M. Eida, and A. B. Ahmed, “Evaluation of polymerase chain reaction on amniotic fluid for diagnosis of congenital toxoplasmosis,” Journal of the Egyptian Society of Parasitology, vol. 39, no. 2, pp. 541–550, 2009. View at Google Scholar · View at Scopus
  19. S. M. B. Dajem and M. A. Almushait, “Detection of Toxoplasma gondii DNA by PCR in blood samples collected from pregnant Saudi women from the Aseer region Saudi Arabia,” Annals of Saudi Medicine, vol. 32, pp. 507–512, 2012. View at Google Scholar
  20. K. Biedermann, M. Flepp, W. Fierz, H. Joller-Jemelka, and P. Kleihues, “Pregnancy, immunosuppression and reactivation of latent toxoplasmosis,” Journal of Perinatal Medicine, vol. 23, no. 3, pp. 191–203, 1995. View at Google Scholar · View at Scopus
  21. W. Rozej-Bielicka, M. Waloch, and E. Gołab, “Cases of Toxoplasma gondii infection in foetus's and toxoplasmic encephalitis in immunosupressed patients confirmed by PCR method in NIPH–NIH, 2009-2010,” Przegļd Epidemiologiczny, vol. 65, no. 4, pp. 593–597, 2011. View at Google Scholar · View at Scopus
  22. C. Chemla, I. Villena, D. Aubert et al., “Preconception seroconversion and maternal seronegativity at delivery do not rule out the risk of congenital toxoplasmosis,” Clinical and Diagnostic Laboratory Immunology, vol. 9, no. 2, pp. 489–490, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Rorman, C. S. Zamir, I. Rilkis, and H. Ben-David, “Congenital toxoplasmosis-prenatal aspects of Toxoplasma gondii infection,” Reproductive Toxicology, vol. 21, no. 4, pp. 458–472, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. R. McLeod, K. Boyer, T. Karrison et al., “Outcome of treatment for congenital toxoplasmosis, 1981–2004: the national collaborative Chicago-based, congenital toxoplasmosis study,” Clinical Infectious Diseases, vol. 42, no. 10, pp. 1383–1394, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. American Academy of Pediatrics, “Summaries of infectious diseases,” in Red Book: 2009 Report of the Committee on Infectious Diseases, L. K. Pickering, C. J. Baker, D. W. Kimberlin, and S. S. Long, Eds., Elk Grove Village, III, USA, 28th edition, 2009. View at Google Scholar
  26. L. Mandelbrot, “Prevention of mother-to-child transmission of toxoplasmosis: perspectives,” Gynecologie Obstetrique & Fertilite, vol. 40, pp. 591–598, 2012. View at Google Scholar
  27. A. E. Czeizel, “Primary prevention of neural-tube defects and some other major congenital abnormalities: recommendations for the appropriate use of folic acid during pregnancy,” Paediatric Drugs, vol. 2, no. 6, pp. 437–449, 2000. View at Google Scholar · View at Scopus
  28. A. Hotop, H. Hlobil, and U. Gross, “Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy,” Clinical Infectious Diseases, vol. 54, pp. 1545–1552, 2012. View at Google Scholar
  29. D. R. Schmidt, B. Hogh, O. Andersen, S. H. Hansen, K. Dalhoff, and E. Petersen, “Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine,” European Journal of Pediatrics, vol. 165, no. 1, pp. 19–25, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Soheilian, M.-M. Sadoughi, M. Ghajarnia et al., “Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis,” Ophthalmology, vol. 112, no. 11, pp. 1876–1884, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Paquet and M. H. Yudin, “Toxoplasmosis in pregnancy: prevention, screening, and treatment,” Journal of Obstetrics and Gynaecology Canada, vol. 35, pp. 78–79, 2013. View at Google Scholar
  32. C. Bachmeyer, G. Mouchnino, P. Thulliez, and L. Blum, “Congenital toxoplasmosis from an HIV-infected woman as a result of reactivation,” Journal of Infection, vol. 52, no. 2, pp. e55–e57, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. M. L. S. Cruz, C. A. Cardoso, M. C. Saavedra, E. dos Santos, and T. Melino, “Congenital toxoplasmosis infection in an infant born to an HIV-1-infected mother,” Brazilian Journal of Infectious Diseases, vol. 11, no. 6, pp. 610–611, 2007. View at Google Scholar · View at Scopus
  34. K. M. L. de Azevedo, S. Sétubal, V. G. S. Lopes, L. A. B. Camacho, and S. A. de Oliveira, “Congenital toxoplasmosis transmitted by human immunodeficiency-virus infected women,” Brazilian Journal of Infectious Diseases, vol. 14, no. 2, pp. 186–189, 2010. View at Google Scholar · View at Scopus
  35. L. Campello Porto and E. C. Duarte, “Association between the risk of congenital toxoplasmosis and the classification of toxoplasmosis in pregnant women and prenatal treatment in Brazil, 1994-2009,” International Journal of Infectious Diseases, vol. 16, pp. 480–486, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Hotop, H. Hlobil, and U. Gross, “Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy,” Clinical Infectious Diseases, vol. 54, pp. 1545–1552, 2012. View at Google Scholar
  37. M. Mombro, C. Perathoner, A. Leone et al., “Congenital toxoplasmosis: 10-year follow up,” European Journal of Pediatrics, vol. 154, no. 8, pp. 635–639, 1995. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Vergani, A. Ghidini, P. Ceruti et al., “Congenital toxoplasmosis: efficacy of maternal treatment with spiramycin alone,” American Journal of Reproductive Immunology, vol. 39, no. 5, pp. 335–340, 1998. View at Google Scholar · View at Scopus
  39. P. Valentini, M. L. Annunziata, D. F. Angelone et al., “Role of spiramycin/cotrimoxazole association in the mother-to-child transmission of toxoplasmosis infection in pregnancy,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 28, no. 3, pp. 297–300, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Tamaru, A. Kikuchi, K. Takagi, M. Wakamatsu, T. Horikoshi, and Y. Ogiso, “Fetal therapy of severe symptomatic toxoplasmosis using azithromycin,” Journal of Obstetrics and Gynaecology Research, vol. 37, no. 7, pp. 953–957, 2011. View at Publisher · View at Google Scholar · View at Scopus